Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
- PMID: 7726912
- DOI: 10.1038/ng0994-27
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Erratum in
- Nat Genet 1994 Dec;8(4):410
Abstract
The MTS1 gene on chromosome 9p21 encodes the p16 inhibitor of cyclinD/Cdk-4 complexes, and is deleted or mutated in a variety of tumour types. We found allelic deletions of 9p21-p22 in 85% of pancreatic adenocarcinomas. Analysis of MTS1 in pancreatic carcinomas (27 xenografts and 10 cell lines) showed homozygous deletions in 15 (41%) and sequence changes in 14 (38%). These included eight point mutations (four nonsense, two missense and two splice site mutations) and six deletions/insertions, all accompanied by loss of the wild-type allele. Sequencing of MTS1 from primary tumours confirmed the mutations. Coexistent inactivations of both MTS1 and p53 was common and suggests that abnormal regulation of cyclin-dependent kinases may play an important role in the biology of pancreatic carcinoma.
Similar articles
-
Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.Cancer Res. 1996 Mar 1;56(5):1137-41. Cancer Res. 1996. PMID: 8640773
-
MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.Oncogene. 1995 Feb 2;10(3):619-22. Oncogene. 1995. PMID: 7845688
-
The MTS1 gene is frequently mutated in primary human esophageal tumors.Oncogene. 1994 Dec;9(12):3737-41. Oncogene. 1994. PMID: 7970734
-
Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.
-
Molecular genetics of exocrine pancreatic neoplasms.Surg Clin North Am. 1995 Oct;75(5):857-69. doi: 10.1016/s0039-6109(16)46732-0. Surg Clin North Am. 1995. PMID: 7660250 Review.
Cited by
-
Pathology and molecular genetics of pancreatic neoplasms.Cancer J. 2012 Nov-Dec;18(6):492-501. doi: 10.1097/PPO.0b013e31827459b6. Cancer J. 2012. PMID: 23187835 Free PMC article. Review.
-
Mouse models of Kras activation in gastric cancer.Exp Mol Med. 2022 Nov;54(11):1793-1798. doi: 10.1038/s12276-022-00882-1. Epub 2022 Nov 11. Exp Mol Med. 2022. PMID: 36369466 Free PMC article. Review.
-
RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.Genes Cancer. 2014 Nov;5(11-12):420-35. doi: 10.18632/genesandcancer.43. Genes Cancer. 2014. PMID: 25568667 Free PMC article.
-
Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team.Int J Pancreatol. 2000 Jun;27(3):181-93. doi: 10.1385/ijgc:27:3:181. Int J Pancreatol. 2000. PMID: 10952400 Review.
-
Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.Ann Surg. 2007 Jul;246(1):61-8. doi: 10.1097/SLA.0b013e318070cafa. Ann Surg. 2007. PMID: 17592292 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous